Ipsen and GENFIT have entered into a long─term strategic partnership for global collaboration between the two companies. The agreement gives Ipsen exclusive worldwide license to develop, manufacture and
Log in met Medi-Access
Wilt u het gehele artikel lezen?
Log in met Medi-Access om verder te lezen
Ipsen, GENFIT ink global collaboration to develop, manufacture & commercialize elafibranor to treat primary biliary cholangitis
Pharma Biz | Geplaatst op 20.12.2021 11:16